NEW YORK (GenomeWeb) – Laboratory Corporation of America said this week that it has developed and launched a noninvasive prenatal test for fetal chromosomal abnormalities. It will offer the test through Integrated Genetics, part of the LabCorp Specialty Group of labs that offer esoteric and genomic testing.

The test, called InformaSeq Prenatal Test, will screen for multiple fetal chromosomal abnormalities and will have testing options for several common sex-related aneuploidies. The test will run on an as of yet unspecified Illumina platform.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.